Richard Johnson
Director of Finance/CFO at Phibro Animal Health (Belgium) SA
Profile
Richard G.
Johnson is currently the Chief Financial Officer at Phibro Animal Health (Belgium) SA. Previously, he held the same position at Phibro Animal Health Corp.
from 2002 to 2020.
Prior to that, he was the Vice President of Planning & Control at Ecolab, Inc. from 1992 to 1999 and the Director of Financial Management at Laserdyne Prima, Inc. from 2000 to 2002.
In 2023, he will return to Phibro Animal Health Corp.
as their Chief Financial Officer for a one-year term.
Richard Johnson active positions
Companies | Position | Start |
---|---|---|
Phibro Animal Health (Belgium) SA
Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Director of Finance/CFO | 2011-06-07 |
Former positions of Richard Johnson
Companies | Position | End |
---|---|---|
PHIBRO ANIMAL HEALTH CORPORATION | Director of Finance/CFO | 2024-02-08 |
PHIBRO ANIMAL HEALTH CORPORATION | Director of Finance/CFO | 2020-11-14 |
Laserdyne Prima, Inc. | Corporate Officer/Principal | 2001-12-31 |
ECOLAB INC. | Corporate Officer/Principal | 1998-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ECOLAB INC. | Process Industries |
PHIBRO ANIMAL HEALTH CORPORATION | Health Technology |
Private companies | 2 |
---|---|
Laserdyne Prima, Inc. | |
Phibro Animal Health (Belgium) SA
Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Process Industries |
- Stock Market
- Insiders
- Richard Johnson